 Effects inhaled budesonide spirometric values reversibility responsiveness cough threshold smokers chronic obstructive lung disease corticosteroids respiratory symptoms responsiveness allergic patients asthma aim present double blind study effect weeks treatment inhaled budesonide non-allergic smokers chronic obstructive lung disease subjects male study ages years mean pack years smoking mean range geometric mean histamine concentration fall mg/ml week washout single blind placebo period patients treatment budesonide microgram/day weeks additional drug ipratropium Twenty patients study budesonide group placebo group standard deviation difference duplicate measurements histamine citric acid cough threshold weeks dose step significant reduction dyspnoea budesonide group change symptom scores use ipratropium bromide weeks treatment groups significant differences spirometric values peak expiratory flow histamine citric acid cough threshold groups differences significant changes trend favour budesonide observation period significant influence inhaled corticosteroids patients chronic obstructive lung disease